Reports for LAMIVUDINE

Ingredient

LAMIVUDINE

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
PMS-ABACAVIR-LAMIVUDINE 600MG 300MG TABLET Resolved 2017-10-12 2018-10-03 25829
PMS-ABACAVIR-LAMIVUDINE 600MG 300MG TABLET Resolved 2018-02-06 2018-08-24 38860
PMS-ABACAVIR-LAMIVUDINE 600MG 300MG TABLET Resolved 2019-03-04 2022-06-23 77526
PMS-ABACAVIR-LAMIVUDINE 600MG 300MG TABLET Resolved 2019-03-04 2022-06-23 77531
TEVA-ABACAVIR/LAMIVUDINE 300MG 600MG TABLET Resolved 2021-10-21 2021-12-17 147699
TRIZIVIR 300MG 300MG 150MG TABLET Resolved 2019-08-02 2021-12-08 90619

Showing 21 to 26 of 26

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-LAMIVUDINE 150MG TABLET Discontinued 2018-09-07 2019-07-13 60557
APO-LAMIVUDINE 300MG TABLET Discontinued 2018-09-07 2019-07-13 60560
APO-LAMIVUDINE HBV 100MG TABLET Discontinued 2018-09-07 2019-12-21 60563
HEPTOVIR 100MG TABLET To be discontinued 2022-05-13 2022-05-13 160500
HEPTOVIR 5MG SOLUTION To be discontinued 2022-05-13 2022-05-13 160503
TEVA-LAMIVUDINE/ZIDOVUDINE 300MG 150MG TABLET Discontinued 2020-01-24 2020-01-24 104260
TRIZIVIR 300MG 300MG 150MG TABLET Discontinued 2019-09-18 2019-09-18 94278

Showing 1 to 7 of 7